학술논문

Improved quality of life among seasonal allergic rhinitis patients treated with olopatadine HC1 nasal spray 0.4% and olopatadine HC1 nasal spray 0.6% compared with vehicle placebo.
Document Type
Article
Source
Allergy & Asthma Proceedings; May/Jun2006, Vol. 27 Issue 3, p202-207, 6p
Subject
ALLERGIC rhinitis
QUALITY of life
PATIENTS
THERAPEUTICS
ANTIALLERGIC agents
RANDOMIZED controlled trials
Language
ISSN
10885412
Abstract
Copyright of Allergy & Asthma Proceedings is the property of OceanSide Publications Inc. and its content may not be copied or emailed to multiple sites or posted to a listserv without the copyright holder's express written permission. However, users may print, download, or email articles for individual use. This abstract may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full abstract. (Copyright applies to all Abstracts.)